Proliferative Diabetic Retinopathy Clinical Trials

113 clinical trials for Proliferative Diabetic Retinopathy across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR — RECRUITING · PHASE3
• Early Vitrectomy vs PRP in Early Proliferative Diabetic Retinopathy — RECRUITING · NA
• Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy — RECRUITING · NA
• Evaluation of safety and efficacy of extraocular LED-illumination during vitreoretinal surgery — RECRUITING
• Prospective, randomized, multicenter, open label phase II study to access efficacy and safety of Lucentis monotherapy (ranibizumab 0.5 mg intravitreal injections) compared with Lucentis plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy. — COMPLETED · PHASE2
• Multicenter randomized open-label three-arms controlled 12 months clinical proof of concept study to evaluate efficacy and safety of Ranibizumab alone or in combination with laser treatment vs. laser treatment alone in Proliferative Diabetic Retinopathy — COMPLETED · PHASE2
• Pain Management During Panretinal Photocoagulation for Diabetic Retinopathy: Safety and Efficacy of Peribulbar Anesthesia — COMPLETED · PHASE4
• High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes — ACTIVE_NOT_RECRUITING · PHASE4
• Genetic Markers and Proliferative Diabetic Retinopathy — COMPLETED · NA
• New Pattern of Retinal Laser Treatment for PDR — NOT_YET_RECRUITING · NA
• UNITY VCS Vitreoretinal Surgery — WITHDRAWN · NA
• Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy — COMPLETED · PHASE3
• Biological Changes in Fibrovascular Membranes of Patients With Proliferative Diabetic Retinopathy Following Faricimab Injection — COMPLETED · NA
• Outcomes of Retinal Re-surgeries in Silicone Oil Filled Eyes — COMPLETED
• Discovering Early Biomarkers in Circulating Endothelial Cells for Diabetes Complications by Single Cell RNA Sequencing — COMPLETED
• VISUPRIME® Eye Drops — COMPLETED · NA
• Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy — OTHER · PHASE2
• HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population — WITHDRAWN · PHASE3
• Changes in Macular Thickness After Patterns Scan Laser — TERMINATED · PHASE4
• Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. — TERMINATED · PHASE4
• Changes in Vitreous Temperature During Phacoemulsification — WITHDRAWN · NA
• Safety and Efficacy of Low-Fluence PRP for PDR — TERMINATED · NA
• Intravitreal Bevacizumab for Diabetic Retinopathy — TERMINATED · PHASE2
• Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment — TERMINATED · PHASE4
• Intravitreal Ozurdex After Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy — COMPLETED · PHASE2
• Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy — COMPLETED · PHASE4
• Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics — OTHER · NA
• A Study on the Treatment Strategy of NVG Secondary to PDR — COMPLETED · NA
• OCT and OCT-A Afer Diabetic Vitrectomy in PDR — OTHER
• Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy — COMPLETED · NA
• Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging — COMPLETED · PHASE1
• Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients — OTHER · PHASE2
• Establishment and Validation of a Risk Prediction Model for Long-term Low Vision After Vitrectomy in PDR Patients — OTHER
• Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy — OTHER · PHASE4
• The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR — COMPLETED · NA
• Efficacy and Safety Comparison of IVR and IVC Before Vitrectomy in Proliferative Diabetic Retinopathy — COMPLETED · NA
• Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR — COMPLETED · NA
• Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy — COMPLETED
• Anti-VEGF in Real-world — OTHER
• Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema — COMPLETED · PHASE4
• Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy — COMPLETED · PHASE3
• Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy — COMPLETED · PHASE2
• Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy — COMPLETED · PHASE2
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — COMPLETED · PHASE2
• Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema — COMPLETED · PHASE2
• Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR — OTHER · PHASE2
• Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy — OTHER · NA
• Pre-vitrectomy Intravitreal Ranibizumab for Patients With Proliferative Diabetic Retinopathy Combined With Diabetic Macular Edema — OTHER · PHASE4
• Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes — COMPLETED · NA
• Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy — COMPLETED · PHASE4

Refine this search